In vitro interaction of the pentasaccharide idraparinux (SanOrg 34006) with unfractionated heparin

被引:5
作者
Gouin-Thibault, I
Dingler, E
Maris, FA
Samama, MM
机构
[1] Grp Hosp Charles Foix Jean Rostand, Hematol Lab, AP HP, Ivry, France
[2] Hop Hotel Dieu, Serv Hematol Biol, F-75181 Paris, France
[3] Organon Dev GMBH, DMK Waltrop Bioanalyt Wirrigen, Waltrop, Germany
[4] NV Organon, Dept Drug Metab & Kinet, NL-5340 BH Oss, Netherlands
关键词
D O I
10.1046/j.1538-7836.2003.00384.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2054 / 2056
页数:3
相关论文
共 8 条
[1]   Protamine inhibits tissue factor-initiated extrinsic coagulation [J].
Chu, AJ ;
Wang, ZG ;
Raicu, M ;
Beydoun, S ;
Ramos, N .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) :392-399
[2]  
DAUB AN, 2001, CLIN APPL THROMB-HEM, V7, P58
[3]   Pharmacokinetics of new synthetic heparin mimetics [J].
Hérault, JP ;
Bernat, A ;
Roye, F ;
Michaux, C ;
Schaeffer, P ;
Bono, F ;
Petitou, M ;
Herbert, JM .
THROMBOSIS AND HAEMOSTASIS, 2002, 87 (06) :985-989
[4]   Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide [J].
Herbert, JM ;
Hérault, JP ;
Bernat, A ;
van Amsterdam, RGM ;
Lormeau, JC ;
Petitou, M ;
van Boeckel, C ;
Hoffmann, P ;
Meuleman, DG .
BLOOD, 1998, 91 (11) :4197-4205
[5]   The synthetic pentasaccharide fondaparinux: First in the class of antithrombotic agents that selectively inhibit coagulation factor Xa [J].
Petitou, M ;
Duchaussoy, P ;
Herbert, JM ;
Duc, G ;
El Hajji, M ;
Branellec, JF ;
Donat, F ;
Necciari, J ;
Cariou, R ;
Bouthier, J ;
Garrigou, E .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (04) :393-402
[6]   Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery - A meta-analysis of 4 randomized double-blind studies [J].
Turpie, AGG ;
Bauer, KA ;
Eriksson, BL ;
Lassen, MR .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (16) :1833-1840
[7]  
WALENGA JM, 1991, THROMB HAEMOSTASIS, V65, P1314
[8]   Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site [J].
Yu, GL ;
LeBrun, L ;
Gunay, NS ;
Hoppensteadt, D ;
Walenga, JM ;
Fareed, J ;
Linhardt, RJ .
THROMBOSIS RESEARCH, 2000, 100 (06) :549-556